Scientific Validation

The effectiveness of treatment with Nurture & Clarity® and Nurture & Clarity-H® has been established and documented by means of a clinical trial conducted at the Pediatric ADHD and Adaptation Clinic of the Sheba Medical Center in Israel, headed by Dr. Miri Katz, a pediatric psychiatrist, as detailed in an article published in The Journal of Attention Disorders.

To summarize the study: 120 children between the age of 6 to 12 years, who had been diagnosed as suffering from ADD or ADHD and who had not been previously treated with any medication, participated in the clinical trial. The participants were divided into 3 groups: a group of 40 children suffering from ADHD; another group of 40 children suffering from ADHD; and a third group, comprising the remaining 40 children diagnosed with ADHD, served as a control group. All the participants underwent a series of tests (TOVA tests, Connors questionnaires, and Achenbach questionnaires for parents) to evaluate their condition, as well as a clinical interview by a pediatric psychiatrist, conducted according to DSM-IV criteria.

During the 4-month treatment period, the children in the first group received 3 cc of Nurture & Clarity® medicinal plant formula and those in the second group received the same quantity of Nurture & Clarity-H® formula – diluted in a quarter cup of water. The formula was taken 3 times a day, shortly before mealtime. The children in the control group received a placebo formula, which was similar in color and taste to the Nurture & Clarity® formulas, however, it contained no medicinal plants.

At the end of the 4-month trial period, all the participants underwent the same tests again, detailed questionnaires were filled out by their parents, and each child was interviewed by a pediatric psychiatrist in order to evaluate the effect of the treatment with Nurture & Clarity® and Nurture & Clarity-H®. The results revealed that, based on the strictest scientific criteria, significant improvement was evident in four different attention-related parameters among the children in the first two groups, while those in the third group (the patients who received the placebo) did not demonstrate any noteworthy improvement. It is important to emphasize that no negative side effects were reported among the participants.

Recommended reading: Article written by Dr. David Rabiner, Senior Research Scientist, Duke University.

 

0 items - $0.00 Checkout View Cart